Literature DB >> 21861083

Three dimensional spectral domain optical coherence tomography features of retinal-choroidal anastomosis.

Giuseppe Querques1, Fernando O Avellis, Lea Querques, Nathalie Massamba, Francesco Bandello, Eric H Souied.   

Abstract

BACKGROUND: To correlate the three-dimensional (3D) spectral-domain optical coherence tomography (SD-OCT) features of retinal-choroidal anastomosis (RCA) to conventional angiography.
METHODS: This is a retrospective chart review of consecutive patients diagnosed with RCA who underwent 3D SD-OCT between July 2007 and June 2010. Main outcome measures were the diagnostic capabilities of 3D SD-OCT, and the correlation between 3D findings and the features distinguished by conventional angiography.
RESULTS: Eighteen eyes of 18 patients [five males, 13 females, mean age 79.5 ± 19.4 years (range, 70-93 years)] were included in the analysis. In eyes (n = 3) showing a focal staining on angiography, 3D OCT revealed a slight convex prominence of the inner retinal surface in correspondence of a small dome-shaped retinal pigment epithelium (RPE) elevation (which represented the early RCA). In eyes (n = 7) showing a "hot spot" without pigment epithelium detachment (PED) on angiography, 3D OCT revealed a convex prominence of the inner retinal surface in correspondence with a well-demarcated prominence of RPE with steep margins (which represented the RCA). In eyes (n = 8) showing a "hot spot" with PED on angiography, 3D OCT revealed a convex prominence of the inner retinal surface in correspondence with a convex RPE prominence with a peak at the top.
CONCLUSIONS: 3D SD-OCT provides a map of the retina and RPE, allowing a realistic visualization of the different pathological features in the disease development, and may be able to provide clinically relevant information to complement angiography in the diagnosis of RCA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21861083     DOI: 10.1007/s00417-011-1804-8

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  21 in total

1.  Clinicopathologic correlation of choroidal and retinal neovascular lesions in age-related macular degeneration.

Authors:  Michael L Klein; David J Wilson
Journal:  Am J Ophthalmol       Date:  2011-01       Impact factor: 5.258

2.  High-resolution Fourier-domain optical coherence tomography of choroidal neovascular membranes associated with age-related macular degeneration.

Authors:  Susanna S Park; Steven N Truong; Robert J Zawadzki; Suhail Alam; Stacey S Choi; David G Telander; John S Werner; Lawrence S Morse
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-10       Impact factor: 4.799

3.  Imaging of chorioretinal anastomoses in vascularized retinal pigment epithelium detachments.

Authors:  D Kuhn; I Meunier; G Soubrane; G Coscas
Journal:  Arch Ophthalmol       Date:  1995-11

4.  Clinicopathological correlation of deep retinal vascular anomalous complex in age related macular degeneration.

Authors:  B A Lafaut; S Aisenbrey; C Vanden Broecke; K U Bartz-Schmidt
Journal:  Br J Ophthalmol       Date:  2000-11       Impact factor: 4.638

5.  Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration.

Authors:  J S Slakter; L A Yannuzzi; U Schneider; J A Sorenson; A Ciardella; D R Guyer; R F Spaide; K B Freund; D A Orlock
Journal:  Ophthalmology       Date:  2000-04       Impact factor: 12.079

Review 6.  Retinal angiomatous proliferation or retinal anastomosis to the lesion.

Authors:  A W Scott; S B Bressler
Journal:  Eye (Lond)       Date:  2009-12-18       Impact factor: 3.775

7.  Tomographic features of intraretinal neovascularization in retinal angiomatous proliferation.

Authors:  Hidetaka Matsumoto; Taku Sato; Shoji Kishi
Journal:  Retina       Date:  2010-03       Impact factor: 4.256

8.  Correlation of high-definition optical coherence tomography and fluorescein angiography imaging in neovascular macular degeneration.

Authors:  Panagiotis Malamos; Stefan Sacu; Michael Georgopoulos; Christopher Kiss; Christian Pruente; Ursula Schmidt-Erfurth
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-06-03       Impact factor: 4.799

9.  Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation.

Authors:  K Bailey Freund; I-Van Ho; Irene A Barbazetto; Hideki Koizumi; Ketan Laud; Daniela Ferrara; Yoko Matsumoto; John A Sorenson; Lawrence Yannuzzi
Journal:  Retina       Date:  2008-02       Impact factor: 4.256

10.  Clinicopathologic correlation of retinal angiomatous proliferation.

Authors:  Dinelli M Monson; Justine R Smith; Michael L Klein; David J Wilson
Journal:  Arch Ophthalmol       Date:  2008-12
View more
  4 in total

1.  Retinal and nonocular abnormalities in Cyp27a1(-/-)Cyp46a1(-/-) mice with dysfunctional metabolism of cholesterol.

Authors:  Aicha Saadane; Natalia Mast; Casey D Charvet; Saida Omarova; Wenchao Zheng; Suber S Huang; Timothy S Kern; Neal S Peachey; Irina A Pikuleva
Journal:  Am J Pathol       Date:  2014-07-25       Impact factor: 4.307

2.  Two- and three-dimensional topographic analysis of pathologically myopic eyes with dome-shaped macula and inferior staphyloma by spectral domain optical coherence tomography.

Authors:  Antonio García-Ben; Radua Kamal-Salah; Ignacio García-Basterra; Ana Gonzalez Gómez; María José Morillo Sanchez; Jose Manuel García-Campos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-01-17       Impact factor: 3.117

3.  Abnormal vascularization in mouse retina with dysregulated retinal cholesterol homeostasis.

Authors:  Saida Omarova; Casey D Charvet; Rachel E Reem; Natalia Mast; Wenchao Zheng; Suber Huang; Neal S Peachey; Irina A Pikuleva
Journal:  J Clin Invest       Date:  2012-07-23       Impact factor: 14.808

4.  Low-Dose Anti-HIV Drug Efavirenz Mitigates Retinal Vascular Lesions in a Mouse Model of Alzheimer's Disease.

Authors:  Nicole El-Darzi; Natalia Mast; David A Buchner; Aicha Saadane; Brian Dailey; Georgios Trichonas; Irina A Pikuleva
Journal:  Front Pharmacol       Date:  2022-06-01       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.